Eli Lilly's Animal-Health Unit Raises $1.5 Billion in IPO
*By Michael Teich*
Wall Street seems to have an appetite for Elanco.
Stock in the animal healthcare start-up that sells antibiotics for pets and livestock surged 50 percent in its market debut Thursday. Shares closed at $36 after pricing at $24 in the IPO ー a price that was already above the expected range of $20 to $23 a share.
Although the company may be relatively unknown to traders, Elanco is a household name among players in the animal healthcare industry, CEO Jeff Simmons told Cheddar.
“We may be new here on Wall Street, but we’re not new in the market for veterinarians and for farmers. We’ve been out there for more than six decades," he said.
Elanco, which spun out of pharmaceutical giant Eli Lilly in July, generates two-thirds of its $2.9 billion in revenue from drugs given to livestock ー cattle and chicken, for example.
The use of antibiotics in livestock has been a polarizing issue among consumers.
In its S-1 IPO filing, the company mentioned one risk to its outlook was the preference for dairy products produced without antibiotics.
Simmons, however, said the trend is actually an opportunity for the company and argued the medication creates safer food products.
“It all starts with a healthy animal. A healthy animal creates safe high quality meat milk and eggs,” he said. “We gotta come on and make sure that animal stays healthy.”
Food animal medicines and vaccines raked in $21.2 billion in revenue in 2017, according to research and consulting firm Vetnosis, and the industry is not expected to slow down any time soon.
According to data firm [Research and Markets](https://www.prnewswire.com/news-releases/global-animal-healthcare-market-2017-2025---a-53-billion-market-potential-300577550.html), the global market for animal healthcare is forecast to be worth $53.42 billion by 2025.
For full interview [click here](https://cheddar.com/videos/animal-medicine-company-elanco-surges-in-market-debut).
Disney content has gone dark on YouTube TV, leaving subscribers of the Google-owned live streaming platform without access to major networks like ESPN and ABC. That’s because the companies have failed to reach a new licensing deal to keep Disney channels on YouTube TV. Depending on how long it lasts, the dispute could particularly impact coverage of U.S. college football matchups over the weekend — on top of other news and entertainment disruptions that have already arrived. In the meantime, YouTube TV subscribers who want to watch Disney channels could have little choice other than turning to the company’s own platforms, which come with their own price tags.
President Donald Trump said he has decided to lower his combined tariff rates on imports of Chinese goods to 47% after talks with Chinese leader Xi Jinping on curbing fentanyl trafficking.
Universal Music Group and AI platform Udio have settled a copyright lawsuit and will collaborate on a new music creation and streaming platform. The companies announced on Wednesday that they reached a compensatory legal settlement and new licensing agreements. These agreements aim to provide more revenue opportunities for Universal's artists and songwriters. The rise of AI song generation tools like Udio has disrupted the music streaming industry, leading to accusations from record labels. This deal marks the first since Universal and others sued Udio and Suno last year. Financial terms of the settlement weren't disclosed.
Nvidia on Wednesday became the first public company to reach a market capitalization of $5 trillion. The ravenous appetite for the Silicon Valley company’s chips is the main reason that the company’s stock price has increased so rapidly since early 2023.
